Free Trial

West Pharmaceutical Services (WST) Earnings Date, Estimates & Call Transcripts

West Pharmaceutical Services logo
$309.77 +9.59 (+3.19%)
Closing price 05/5/2026 03:59 PM Eastern
Extended Trading
$311.08 +1.31 (+0.42%)
As of 05:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services Earnings Summary

West Pharmaceutical Services posted Q1 2026 earnings on April 23, 2026, reporting an EPS of $2.13, which topped the consensus estimate of $1.68 by $0.45. Quarterly revenue rose 21.0% year-over-year to $844.90 million, above the consensus estimate of $779.68 million. With a trailing EPS of $7.48 and a P/E Ratio of 41.41, West Pharmaceutical Services' earnings are expected to grow 9.64% next year, from $8.61 to $9.44 per share.

Upcoming Q2
Earnings Date
Jul. 23Before Market OpensEstimated
Consensus EPS
(Apr. 23)
$1.68
Actual EPS
(Apr. 23)
$2.13 Beat By $0.45
Actual Revenue
(Apr. 23)
$844.90M

Q1 2026 Earnings Resources

WST Upcoming Earnings

West Pharmaceutical Services' next earnings date is estimated for Thursday, July 23, 2026, based on past reporting schedules.

Get West Pharmaceutical Services Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on West Pharmaceutical Services and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

WST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

West Pharmaceutical Services Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20262$1.66$1.66$1.66
Q2 20262$1.98$1.98$1.98$818.7 M2.050 - 2.120$830.0 M - $850.0 M
Q3 20262$2.05$2.05$2.05
Q4 20262$2.11$2.17$2.14
FY 2026 8 $7.80 $7.86 $7.83
Q1 20271$1.82$1.82$1.82
Q2 20271$2.26$2.26$2.26
Q3 20271$2.21$2.21$2.21
Q4 20271$2.51$2.51$2.51

West Pharmaceutical Services Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/23/2026
(Estimated)
--------
4/23/2026Q1 2026$1.68$2.13+$0.45$1.92$779.68M$844.90M
2/12/2026Q4 2025$1.83$2.04+$0.21$1.82$795.70M$805.00M
10/23/2025Q3 2025$1.67$1.96+$0.29$1.92$788.42M$804.60M
7/24/2025Q2 2025$1.51$1.84+$0.33$1.82$725.11M$766.50M
4/24/2025Q1 2025$1.22$1.45+$0.23$1.23$685.24M$698.00M
2/13/2025Q4 2024$1.75$1.82+$0.07$1.78$739.59M$748.80M
10/24/2024Q3 2024$1.50$1.85+$0.35$1.85$709.62M$746.90M
7/25/2024Q2 2024$1.74$1.52 -$0.22$1.53$729.36M$702.10M

Data powered by Fiscal.ai.

West Pharmaceutical Services Earnings - Frequently Asked Questions

West Pharmaceutical Services has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 23rd, 2026 based off last year's report dates. Learn more on WST's earnings history.

West Pharmaceutical Services updated its second quarter 2026 earnings guidance on Thursday, April, 23rd. The company provided earnings per share (EPS) guidance of 2.050-2.120 for the period, compared to the consensus estimate of 2.000. The company issued revenue guidance of $830.0 million-$850.0 million, compared to the consensus revenue estimate of $818.7 million.

In the previous quarter, West Pharmaceutical Services (NYSE:WST) reported $2.13 earnings per share (EPS) to beat the analysts' consensus estimate of $1.68 by $0.45. Learn more on analysts' earnings estimate vs. WST's actual earnings.

The conference call for West Pharmaceutical Services' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for West Pharmaceutical Services' latest earnings report can be read online.
Read Transcript

West Pharmaceutical Services' earnings report can be found in their filing with the SEC.
View SEC filing

West Pharmaceutical Services (NYSE:WST) has a recorded annual revenue of $3.07 billion.

West Pharmaceutical Services (NYSE:WST) has a recorded net income of $493.70 million. WST has generated $7.48 earnings per share over the last four quarters.

West Pharmaceutical Services (NYSE:WST) has a trailing price-to-earnings ratio of 41.41 and a forward price-to-earnings ratio of 35.98. The price/earnings-to-growth ratio is 2.51.

West Pharmaceutical Services' earnings are expected to grow from $8.61 per share to $9.44 per share in the next year, which is a 9.64% increase.


This page (NYSE:WST) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners